TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression

Cancer-related inflammation

Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399

Myeloid-derived-suppressor cells as regulators of the immune system

Gabrilovich, D. I., & Nagaraj, S. (2009) · Nature Reviews Immunology · doi:10.1038/nri2506 · Cited by 6,753

Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome

Galon, J., Costes, A., Sanchez-Cabo, F., Kirilovsky, A., Mlecnik, B., Lagorce-Pagès, C., Tosolini, M., Camus, M., Berger, A., Wind, P., et al. (2006) · Science · doi:10.1126/science.1129139 · Cited by 6,516

Smad-dependent and Smad-independent pathways in TGF-β family signalling

Derynck, R., & Zhang, Y. E. (2003) · Nature · doi:10.1038/nature02006 · Cited by 5,498

IL-17 and th17 cells

Korn, T., Bettelli, E., Oukka, M., & Kuchroo, V. K. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132710 · Cited by 4,873

TGFβ in Cancer

Massagué, J. (2008) · Cell · doi:10.1016/j.cell.2008.07.001 · Cited by 3,907

Microenvironmental regulation of metastasis

Joyce, J. A., & Pollard, J. W. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2618 · Cited by 3,684

TGFβ in the Context of an Inflammatory Cytokine Milieu Supports De Novo Differentiation of IL-17-Producing T Cells

Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M., & Stockinger, B. (2006) · Immunity · doi:10.1016/j.immuni.2006.01.001 · Cited by 3,605

Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN

Fridlender, Z. G., Sun, J., Kim, S., Kapoor, V., Cheng, G., Ling, L. E., Worthen, G. S., & Albelda, S. Μ. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.06.017 · Cited by 3,470

Transforming growth factor-β induces development of the TH17 lineage

Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D., Wahl, S. M., Schoeb, T. R., & Weaver, C. T. (2006) · Nature · doi:10.1038/nature04754 · Cited by 3,087

Modeling Cancer Immunoediting in Tumor Microenvironment with System Characterization through the Ising-model HamiltonianPreprint

Rojas‐Domínguez, A., Arroyo-Duarte, R., Rincón-Vieyra, F., & Alvarado, M. (2021) · Research Square · doi:10.21203/rs.3.rs-746701/v1 · Cited by 3

TGFBR2 High mesenchymal glioma stem cells phenocopy regulatory T cells to suppress CD4+ and CD8+ T cell functionPreprint

Johnson, A., Khela, H. S., Korleski, J., Sall, S., Li, Y.-Q., Zhou, W., Smith-Connor, K., López-Bertoni, H., & Laterra, J. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.07.631757 · Cited by 3

Highly potent novel multi-armoured IL13Ra2 CAR-T subverts the immunosuppressive microenvironment of GlioblastomaPreprint

Mangolini, M., Srivastava, S., Souster, E., Yang, Y., Wang, H., Karattil, R., Schultz, L., Ma, B., Pombal, D., Greenig, M., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.01.10.632392 · Cited by 4

Targeting Tregs in pancreatic ductal adenocarcinoma

Siegel, M., Prabhu, A., Hussain, S., Nwachukwu, D., & Ali, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-23523-8.00015-8 · Cited by 2

Potential molecular mechanisms of ETV6-RUNX1-positive B progenitor cell cluster in acute lymphoblastic leukemia revealed by single-cell RNA sequencing

Qu, N., Wan, Y., Sui, X., Sui, T., & Yang, Y. (2024) · PeerJ · doi:10.7717/peerj.18445 · Cited by 2

Skin-Resident γδ T Cells Mediate Potent and Selective Antitumor Cytotoxicity through Directed Chemotactic Migration and Mobilization of Cytotoxic Granules

Yang, J., Liu, Z., Hu, X., Zhang, X., Huang, Y., Chen, Y., Chen, C., Shang, R., Tang, Y., Hu, W., et al. (2024) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.10.607 · Cited by 2

Integrating Gene Regulatory Network Dynamics with Heterogeneous Stem Cell Regeneration

Li, Y., Liang, X., & Lei, J. (2025) · CSIAM transactions on life sciences. · doi:10.4208/csiam-ls.so-2024-0009 · Cited by 2

Targeting archetypes of viral-driven cancers with immunotherapy: a perspective on immunogenicity within the tumor microenvironment

Lee, K., Kim, S., Zhao, J., & Neo, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1631258 · Cited by 2

An RGD motif on SARS-CoV-2 Spike induces TGF-β signaling and downregulates interferon

Gracie, N. P., Aggarwal, A., Luo, R., Spicer, M., Idrees, S., Ashley, C. L., Alca, S., Ison, T., Steain, M. C., Patel, K., et al. (2025) · Journal of Virology · doi:10.1128/jvi.00435-25 · Cited by 2

Is cancer the result of uncontrolled cellular growth? a glance into the tumorigenic process

Castro‐Oropeza, R., Chávez‐González, A., Mantilla, A., Tachiquín, M. E. R., Mayani, H., & Piña-Sánchez, P. (2026) · Cancer Cell International · doi:10.1186/s12935-026-04253-y · Cited by 3

Signaling pathways related to interstitial cystitis

Wang, H., Liu, S., Sun, Y., & Wang, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1774072 · Cited by 2

Kleine Moleküle, ganz groß: niedermolekulare immunonkologische Kombinationstherapien

Huck, B. R., Kötzner, L., & Urbahns, K. (2017) · Angewandte Chemie · doi:10.1002/ange.201707816 · Cited by 2

L’instabilité génomique, paramètre limitant l’efficacité des thérapies ciblées en oncologie

Billaud, A., Chevalier, L.-M., Campone, M., Morel, A., & Bigot, F. (2020) · Bulletin du Cancer · doi:10.1016/j.bulcan.2020.08.010 · Cited by 3

Cancer cell development, migratory response, and the role of the tumor microenvironment in invasion and metastasis

Antón, I. M., Wandosell, F. G., & Vicente‐Manzanares, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90195-6.00002-4 · Cited by 2

Autophagy inactivation in osteosarcoma leads to the appearance of poor prognosis-associated factors

Camuzard, O., Nollet, M., Santucci‐Darmanin, S., Trojani, M.-C., Abderrahman, N. B., Virolle, V., Burel‐Vandenbos, F., Pagnotta, S., Orange, F., Kolano-Merlin, E., et al. (2022) · Autophagy Reports · doi:10.1080/27694127.2022.2112125 · Cited by 2

Reversing the NK inhibitory tumor microenvironment by targeting suppressive immune effectors

Navin, I., & Parihar, R. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-822620-9.00011-2 · Cited by 2

TGF-β Type II Receptor Punt Suppresses Antimicrobial Peptide Expression and Influences Development in Tribolium castaneum

Li, J., Lyu, B., & Song, Q. (2023) · Insects · doi:10.3390/insects14060515 · Cited by 2

Pan-cancer analysis of the oncogenic role of the core osteosarcoma gene VCAN in human tumors.

Zhou, H., Lu, D., Yu, D., Luo, C., Xie, K., Ma, H., Li, S., Liang, J., Wei, F., Chen, L., et al. (2023) · PubMed Central · Cited by 2

Unveiling the role of HACE1 in cervical cancer: implications for human papillomavirus infection and prognosis

Xiang, S., Wang, M., Li, Q., & Yang, Z. (2024) · Translational Cancer Research · doi:10.21037/tcr-23-2120 · Cited by 2

Identification and Validation of Tumor Microenvironment-Associated Signature in Clear-Cell Renal Cell Carcinoma through Integration of DNA Methylation and Gene Expression

Ye, Z., Xu, J., Zhang, X., Zhang, Y., Ivanova, D., Lu, W., Zhang, J., Li, F., Chen, X., Wang, Y., et al. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25126792 · Cited by 2

Resistance to spindle inhibitors in glioblastoma depends on STAT3 and therapy induced senescence

Zarco, N., Dovas, A., Farias, V., Nagaiah, N. K. H., Haddock, A. N., Sims, P. A., Hambardzumyan, D., Meyer, C. T., Canoll, P., Rosenfeld, S. S., et al. (2024) · iScience · doi:10.1016/j.isci.2024.111311 · Cited by 2

Allopurinol abates hepatocellular carcinoma in rats via modulation of NLRP3 inflammasome and NF-κB pathway

Bahriz, H. A., Abdelaziz, R. R., & El‐Kashef, D. H. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03666-8 · Cited by 2

Mathematical Modeling of Heterogeneous Stem Cell Regeneration: From Cell Division to Waddington’s Epigenetic Landscape

Lei, J. (2025) · Lecture notes on mathematical modelling in the life sciences · doi:10.1007/978-3-031-82396-1_4 · Cited by 2

Biological Microniches Characterizing Pathological Lesions

Meraz, I. M., Segura-Ibarra, V., Leonard, F., Gonzalez, J., Ally, S., Godin, B., & Serda, R. E. (2013) · Frontiers of nanoscience · doi:10.1016/b978-0-08-098338-7.00006-6 · Cited by 2

Differential Influence of Inositol Hexaphosphate on the Expression of Genes Encoding TGF-βIsoforms and Their Receptors in Intestinal Epithelial Cells Stimulated with Proinflammatory Agents

Kapral, M., Wawszczyk, J., Sośnicki, S., & Węglarz, L. (2013) · Mediators of Inflammation · doi:10.1155/2013/436894 · Cited by 2

Novel Immunologic Adjuvants

Rappuoli, R., & Gregorio, E. D. (2011) · doi:10.2217/9781780840048 · Cited by 2

Inducing a humoral immune response to pancreatic cancer antigen

Seifert, M., Seifert, G. J., Wolff-Vorbeck, G., Langenmair, E. R., Hopt, U. T., & Wittel, U. A. (2016) · Cellular Immunology · doi:10.1016/j.cellimm.2016.09.002 · Cited by 2

Navigating Molecular Pathways: An Update on Drugs in Colorectal Cancer Treatment

Maurya, N. S., & Mani, A. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666230614165548 · Cited by 2

Experimental and Computational Studies Reveal Novel Interaction of Lymphocytes Antigen 6K to TGF-β Receptor Complex

Andrys‐Olek, J., Selvanesan, B. C., Varghese, S., Arriaza, R. H., Tiwari, P. B., Chruszcz, M., Borowski, T., & Upadhyay, G. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241612779 · Cited by 2

Hepatic Stellate Cells in the Context of Liver Fibrosis

Khan, M. A., & Ali, R. (2013) · Khyber Medical University Journal · Cited by 2

Estramustine Phosphate Inhibits TGF-β-Induced Mouse Macrophage Migration and Urokinase-Type Plasminogen Activator Production

Mojsilovic, S. S., Mojsilović, S., Bjelica, S., & Santibañez, J. (2018) · Analytical Cellular Pathology · doi:10.1155/2018/3134102 · Cited by 3

Stromal Markers of Breast Cancer Progression: A Review of Recent Findings

Tata, N., Al-Zubeidy, B., & Kulkarni, S. (2019) · Current Surgery Reports · doi:10.1007/s40137-019-0242-0 · Cited by 2

Ductal carcinoma in situ of the breast with osteoclast-like giant cells: A case report with immunohistochemical analysis

Jamiyan, T., Kuroda, H., Hayashi, M., Abe, A., Shimizu, K., & Imai, Y. (2020) · Human Pathology Case Reports · doi:10.1016/j.ehpc.2020.200383 · Cited by 2

Phenotypic plasticity and lineage switching in prostate cancer

Somarelli, J. A., Armstrong, A. J., Sheth, M. U., Ware, K. E., & Jolly, M. K. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-817996-3.00021-9 · Cited by 2

Immunometabolism and Its Potential to Improve the Current Limitations of Immunotherapy

Sheppard, A. D., & Lysaght, J. (2020) · Methods in molecular biology · doi:10.1007/978-1-0716-0802-9_17 · Cited by 2

Polymorphonuclear Neutrophils and Tumors: Friend or Foe?

Klink, M., & Sułowska, Z. (2013) · Springer eBooks · doi:10.1007/978-3-7091-1300-4_7 · Cited by 2

Transforming Growth Factor-Beta in Prostate Cancer

Danielpour, D. (2013) · Springer eBooks · doi:10.1007/978-1-4614-6828-8_7 · Cited by 2

Relación estructura/actividad de proantocianidinas procedentes de fuentes naturales de origen vegetal

Mateos‐Martín, M. L. (2013) · DIGITAL.CSIC (Spanish National Research Council (CSIC)) · doi:10.13039/501100004837

Epithelial–Mesenchymal Transition: A Link between Cancer and Inflammation

Fuxe, J., & Karlsson, M. C. I. (2014) · Wiley eBooks · doi:10.1002/9781118826621.ch3 · Cited by 2

Molecular strategies to reduce unnecessary repeat prostate biopsies of men with elevated serum PSA

Pang, K. H. (2018) · Cited by 2

Deciphering the prognostic and therapeutic significance of BAG1 and BAG2 for predicting distinct survival outcome and effects on liposarcoma

Lian, Y., Chen, J., Han, J., Zhao, B., Wu, J., Li, X., Yue, M., Hou, M., Wu, T., Ye, T., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-67659-6 · Cited by 1

Identification of Molecular Subtypes and Prognostic Features of Breast Cancer Based on TGF-β Signaling-related Genes

Qu, J., Wang, M., Gao, Y.-H., & Zhang, H. (2025) · Cancer Informatics · doi:10.1177/11769351251316398 · Cited by 2

N-glycosylation of ACTRIIB enhances protein stability leading to rapid cell proliferation and strong resistance to docetaxel in nasopharyngeal carcinoma

Qin, Q., Li, J., Shao, Y., Liu, L., & Luo, Z. (2025) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x2024e14368 · Cited by 1

Intrinsic disorder in protein interaction networks linking cancer with metabolic diseases

Vangala, V. N. P., & Uversky, V. N. (2025) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2025.108493 · Cited by 1

UNC93B1: a novel immune−related prognostic biomarker in breast cancer

Tian, L., Zeng, H., Tian, L., Wang, H., & Liu, W. Y. (2025) · Discover Oncology · doi:10.1007/s12672-025-03124-8 · Cited by 1

TLL1 knockdown attenuates prostate cancer progression by enhancing antitumor immunity

Hao, J., He, J., Hu, H., Zhu, Z., Zhao, X., Wu, X.-Y., Li, L., Ruan, Y., Yang, J., Luo, X., et al. (2025) · Oncogene · doi:10.1038/s41388-025-03517-7 · Cited by 1

TGF-β-activated NK-92 cell therapy for esophageal squamous cell carcinoma

Zhang, H., Guo, M., Zhai, Y., Li, F., Hu, W., Zhang, Y., Yang, S., & Huang, L. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115329 · Cited by 1

GPR108 deficiency promotes urate-induced renal interstitial fibrosis

Xu, D., Yang, P., Song, W., Liao, K., Zang, D., Zhou, Q., & Zhou, H. (2025) · Cellular Signalling · doi:10.1016/j.cellsig.2025.112129 · Cited by 1

Defining treatment-resistant brain cancer: Genetic screening to identify oncogene-driven immunomodulation and therapy resistance

Myers, Z. D., & Matosevic, S. (2025) · Cancer Gene Therapy · doi:10.1038/s41417-025-00980-y · Cited by 2

Oncogenesis in cholangiocarcinoma

Orzan, R. I., & Seicean, A. (2025) · Advances in clinical chemistry · doi:10.1016/bs.acc.2025.10.008 · Cited by 1

MiR ‐490‐3p/ TGFBR1 Axis Prevents Atrial Fibrillation by Inhibiting Cellular Fibrosis

Zhang, X., & Yu, Z. (2025) · Apmis · doi:10.1111/apm.70098 · Cited by 1

ROS-Responsive MnO2 nanozyme co-delivering cGAMP and TGF-β inhibitor synergistically activates STING signaling and remodels the immunosuppressive thyroid cancer microenvironment

Liu, G., & Li, R. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04346-w · Cited by 1

Pulmonary fibrosis and the TGF-β signaling axis: Advances in targeted therapeutics

Wang, Y., Xu, Y., Zhang, Y., Wang, B., Liu, X., & Zhang, H. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.179174 · Cited by 1

Toll-Like Receptors as Novel Therapeutic Targets for the Treatment of Pancreatic Cancer

Kelly, D., Benencia, F., Leonard, D., Malgor, R., Schwartz, A., & Frank, L. (2012) · InTech eBooks · doi:10.5772/27263 · Cited by 2

Realizing the promise of breast cancer vaccines

Soliman, H. H., & Jackson, J. (2012) · Vaccine Development and Therapy · doi:10.2147/vdt.s25532 · Cited by 1

Molecular Biology of the Oral Cancer

Sasahira, T., & Kuniyasu, H. (2015) · Springer eBooks · doi:10.1007/978-4-431-54938-3_3 · Cited by 1

Development of Novel Anti-Cancer Immunotherapy Targeting Immune Evasion Mechanisms

Tamada, K. (2012) · Yamaguchi Medical Journal · doi:10.2342/ymj.61.5 · Cited by 1

A novel role of hepatic epithelial transforming growth factor-β signaling in cholangiocarcinogenesis

Liu, M., Mok, M. T. S., & Cheng, A. S. L. (2016) · Annals of Translational Medicine · doi:10.21037/atm.2016.03.01 · Cited by 1

HNSCC Biomarkers Derived from Key Processes of Cancerogenesis

Raudenská, M., Gumulec, J., Fribley, A. M., & Masařík, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-27647-2_7 · Cited by 1

Differentiation plasticity of human monocytes in culture

(2020) · Биомедицинска истраживања · doi:10.5937/bii2001001j · Cited by 1

The dual role of Natural Killer cells during tumor progression and angiogenesis: Implications for tumor microenvironment-targeted immunotherapies

Mortara, L., Baci, D., Coco, G., Poggi, A. D., & Bruno, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-824375-6.00014-x · Cited by 1

Limited Efficacy of Decreased Tumor-infiltrating Regulatory T Cells after Transforming Growth Factor-beta Blockade in Murine Pancreatic Ductal Adenocarcinoma

Zhao, G., Pu, N., Nuerxiati, A., Yin, H.-L., Zhang, L., Lou, W., & Wu, W. (2022) · Cancer Screening and Prevention · doi:10.14218/csp.2022.00001 · Cited by 1

Hyperprogression under treatment with immune-checkpoint inhibitors in patients with gastrointestinal cancer: A natural process of advanced tumor progression?

Wang, M.-X., Gao, S.-Y., Yang, F., Fan, R., Yang, Q.-N., Zhang, T., Qian, N., & Guang-hai, D. (2022) · World Journal of Clinical Oncology · doi:10.5306/wjco.v13.i9.729 · Cited by 1

Transforming Growth Factor-β1 and Tumor Development

Dahl, L. (2023) · Science Insights · doi:10.15354/si.23.re298 · Cited by 1

Effect of the Secretome of Mesenchymal Placenta Stem Cells on the Functional Properties of Lewis Lung Carcinoma Cells In Vitro

Garmanchuk, L., Ostrovska, G. V., Stupak, I. A., Bukreieva, T., Gorbach, O. I., & Остапченко, Л. І. (2024) · Cytology and Genetics · doi:10.3103/s0095452724040054 · Cited by 1

Comparative Ability of Various Immunosuppressants as Adjuvants on the Activity of T1D Vaccine

Wang, X., Xie, M., Li, T., Shi, J., Wu, M., Zhang, S., Sun, J., & Hu, Y. (2024) · Vaccines · doi:10.3390/vaccines12101117 · Cited by 1

Quantification of Vactosertib an Inhibitor of TGFBR1 by LC–MS/MS in Rat Plasma and Its Pharmacokinetic Profiling

Boggavarapu, R. K., Chimakurthy, J., & Konidala, S. K. (2024) · Biomedical Chromatography · doi:10.1002/bmc.6057 · Cited by 1

TGFBR2 as a prognostic marker and therapeutic target in benzo(a)pyrene-associated esophageal cancer: insights from multi-omics analysis

Zhou, H., Lv, X., Chen, Y., & Qin, Z. (2025) · Toxicology Mechanisms and Methods · doi:10.1080/15376516.2025.2495930 · Cited by 1

A Dose-Dependent Study Examining Dexmedetomidine’s Possible Effects Against Oxidative, Fibrotic, and Apoptotic Damage Induced by Radiation Exposure in Spleen Tissue

Polat, H. B., Yılmaz, H., Kılınç, K., Gülhan, B., Rakıcı, S. Y., & Tümkaya, L. (2025) · Life · doi:10.3390/life15091430 · Cited by 1

Particulate matter exposure negatively affects the cancer immunosurveillance through PD-L1 upregulation and dendritic cell maturation suppression

Panya, A., Wutti‐in, Y., Thepmalee, C., Yabueng, N., Chantara, S., Kewcharoenwong, C., Lertmemongkolchai, G., Vongchan, P., & Klangsinsirikul, P. (2025) · Journal of Environmental Sciences · doi:10.1016/j.jes.2025.09.069 · Cited by 1

TGF-β in Development and Ageing

Pratsinis, H., Mavrogonatou, E., & Kletsas, D. (2017) · Healthy ageing and longevity · doi:10.1007/978-3-319-63001-4_7 · Cited by 3

NK Cells and Cancer

Sabry, M., & Lowdell, M. W. (2017) · InTech eBooks · doi:10.5772/intechopen.69658 · Cited by 1

Melanoma Brain Metastasis: Insights, Progress, Challenges, and Opportunities

Fischer, G. M., & Davies, M. A. (2019) · Springer eBooks · doi:10.1007/978-1-4614-7322-0_44-1 · Cited by 1

Study of association between molecular marker expression on tumor and immunocompetent cells and sensitivity to adjuvant and neoadjuvant therapy of bladder cancer

Zaborskii, I. N., Иванов, С. А., Mushkarina, Т. Y., Karyakin, O. B., Кузьмина, Е. Г., Сафиуллин, К. Н., Chaykov, V. S., Troyanov, A. V., Dementev, I. O., Kasymov, M. R., et al. (2019) · Cancer Urology · doi:10.17650/1726-9776-2019-15-2-100-106 · Cited by 1

Effect of tagitinin C isolated from Tithonia diversifoli (Hemsley) A Gray on migration activity and TGF-β1 levels on keloid fibroblast

santi, E., Wahyuningsih, M. S. H., & Budiyanto, A. (2019) · Journal of the Medical Sciences (Berkala Ilmu Kedokteran) · doi:10.19106/jmedsci005103201901 · Cited by 1

Interleukin-6 (IL-6), Interleukin-8 (IL-8), and Tumor Necrosis FactorAlpha (TNF-a): Their Role in the Development and Metastasis of Tumor Cells

Adnyana, I. G. A. (2019) · Sains Medika Jurnal Kedokteran dan Kesehatan · doi:10.30659/sainsmed.v10i2.4184 · Cited by 1

p.P476S mutation of RBPJL inhibits the efficacy of anti‐PD‐1 therapy in oesophageal squamous cell carcinoma by blunting T‐cell responses

Miao, L., Wei, X., Zhao, Q., Qi, J., Ren, C., Wu, Q., Wei, D., Liu, J., Wang, F., & Xu, R. (2020) · Clinical & Translational Immunology · doi:10.1002/cti2.1172 · Cited by 1

Human Cancer: Epidemiology, Hallmarks, and Defense Strategies

Wong, B. S., Wong, C. W., & Wong, F. C. (2020) · Springer eBooks · doi:10.1007/978-3-030-56267-0_1 · Cited by 1

Blockade of TGF-βR improves the efficacy of doxorubicin by modulating the tumor cell motility and affecting the immune cells in a melanoma model

Mardomi, A., Ghollasi, M., Korani, M., Panahi, M., Parsa‐kondelaji, M., Sabzichi, M., & Salimi, A. (2021) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-021-02134-x · Cited by 1

Biomarker mRNAs for staging and prognosis of colorectal cancer

Ohlsson, L. (2011) · KTH Publication Database DiVA (KTH Royal Institute of Technology) · Cited by 1

Preclinical development of adoptive T-cell immunotherapy for EBV-associated diseases using third-party donors

Frumento, G. (2018) · University of Birmingham Institutional Research Archive (University of Birmingham) · Cited by 1

Immuntherapie des Pankreaskarzinoms

Ellermeier, J. (2013) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.16522 · Cited by 1

Exploration of prognostic value and underlying mechanism of P2RY14 in triple negative breast cancer by multi-omicsPreprint

Lai, S., Wang, S., Ma, R., Li, X., & Mao, M. (2023) · Research Square · doi:10.21203/rs.3.rs-2795229/v1 · Cited by 1

Tumor specific TGF-β insensitive CD8 + T cells augments the antitumor effect through inhibition of epithelial-mesenchymal transition in CD 105 + renal carcinoma stem cellsPreprint

Wang, L., Zhang, C., Yue, D.-Z., & Dong, J. (2024) · Research Square · doi:10.21203/rs.3.rs-3972286/v1 · Cited by 1

An integrated multi-omics investigation of W-NK1, a cytokine-primed non-engineered natural killer cell therapy productPreprint

Arthur, L., Mahajan, N., Vadakekolathu, J. N., Leedom, T. A., Boocock, D. J., Coveney, C., Hamil, A., Magee, K. L., Dean, J., Schramm, E. C., et al. (2024) · medRxiv · doi:10.1101/2024.07.08.24310018 · Cited by 1

Molecular prognostic markers in soft tissue sarcomas

Valkov, A. Y. (2012) · NORA - Norwegian Open Research Archives · Cited by 1

Subgroups of Merkel cell carcinoma patients defined by young age, immunodeficiency and polyomavirus infection

Sahi, H. (2014) · Työväentutkimus Vuosikirja

Dietary- and fasting-based interventions as novel approaches to improve the efficacy of cancer treatment

Brandhorst, S. (2013) · DuEPublico (University of Duisburg-Essen)

Initiation and progression of Müllerian duct derived malignancies

van der Horst, P. (2013)

Adipose-Derived Progenitor Cell Alterations To The Tumor Microenvironment Promote Tumorigenesis

Brooks, E. (2012) · eCommons (Cornell University)

Immune escape in chronic leukemia

Werlenius, O. (2015) · Gothenburg University Publications Electronic Archive (Gothenburg University)

A systems biology approach to target identification using three-dimensional multi-cellular tumour spheroids (MCTS). Regio-specific molecular dissection of gene expression, protein expression and functional activity in 3D MCTS.

McMahon, K. M. (2011) · Bradford Scholars (University of Bradford)

CD40L Gene Therapy for Solid Tumors

Liljenfeldt, L. (2014) · Uppsala University Publications (Uppsala University)

The role of short-term starvation in sensitizing breast cancer to chemotherapy

Govender, Y. (2013) · SUNScholar (Stellenbosch University)

Treatment-Induced Autophagy Associated with Tumor Dormancy and Relapse

Gewirtz, D. A. (2016)

The Role of Cancer-associated Fibroblasts in the Stemness of Gastric Cancer Stem Cells

(2014) · Cancer Cell & Microenvironment · doi:10.14800/ccm.277

Assessment of therapeutic targets in experimental models of Myc-induced lymphoma

Forshell, L. P. (2011)

STUDIES ON THE MECHANISMS OF CARCINOGENESIS AND CANCER CELL DEATH

Li, Q. (2013) · Figshare

TGFß, a Potent Regulator of Tumor Microenvironment and Host Immune Response, Implication for Therapy

Yang, H. H. (2010) · Current Molecular Medicine · doi:10.2174/156652410791317039 · Cited by 46

REVIEW ARTICLE Regulation of Tumor Immune Surveillance and Tumor Immune Subversion by TGF-β

Park, H.-Y., Wakefield, L. M., & Mamura, M. (2013)

Regulation of Tumor Immune Surveillance and Tumor Immune Subversion by TGF-β

Park, H., Wakefield, L. M., & Mamura, M. (2009) · Immune Network · doi:10.4110/in.2009.9.4.122 · Cited by 24

TGF-β and tumors — an ill-fated alliance

Moutsopoulos, N. M., Wen, J., & Wahl, S. M. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.04.003 · Cited by 58

TGF-beta: a master switch in tumor immunity

Gigante, M., Gesualdo, L., & Ranieri, E. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802430378 · Cited by 45